Encube Ethicals Limited

rhp filed

Source: SEBI

Issue price

—

Issue size

₹3,000 Cr

Fresh issue

—

Offer for sale

₹3,000 Cr

Bull / base / bear

What would have to hold for each case — not a price target or a projected figure. CapitSignal does not forecast where this stock trades.

Encube successfully expands its product portfolio in the US and European markets.
The company has a significant addressable market in the US, UK, and Germany, projected to grow from USD 8 billion in Fiscal 2026 to USD 13 billion.
The company maintains its strong compliance track record and continues to avoid regulatory issues.
Encube has demonstrated zero Official Action Indicated classifications and zero product recalls since inception.

Encube's revenue growth continues at the current trajectory.
The company reported a total revenue from operations of ₹18,487 million in Fiscal 2026, reflecting a CAGR of 30.48% from Fiscal 2024 to 2026.
The company retains its customer base and does not lose significant accounts.
The top 10 customers contributed 59.74% of total revenue in Fiscal 2026, indicating a high customer concentration risk.

Regulatory investigations lead to penalties or operational disruptions.
The United States Department of Justice is investigating whether Encube Ethicals Inc caused false claims to Medicare, which could adversely affect operations.
Supply chain disruptions occur due to reliance on third-party suppliers.
The company sources a significant portion of its raw materials from a limited number of suppliers, contributing to 35.40% of total purchases in Fiscal 2026.